Evidence map›Paper›PMID 34009138›Full record

ArticleEndocrine connections2021

The evolving role of whole-exome sequencing in the management of disorders of sex development.

Yardena Tenenbaum-Rakover, Osnat Admoni, Ghadir Elias-Assad, Shira London, Marie Noufi-Barhoum, Hanna Ludar, Tal Almagor, Yoav Zehavi, Charles Sultan, Rita Bertalan and 2 more

Open access · goldAbstract read
In one paragraph

Article in Endocrine connections, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 4 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 4 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Cis-Regulatory Control of Mammalian Sex Determination.Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation · 2021
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Yardena Tenenbaum-RakoverPediatric Endocrine Institute, Ha'Emek Medical Center, Afula, Israel.
Osnat AdmoniPediatric Endocrine Institute, Ha'Emek Medical Center, Afula, Israel.
Ghadir Elias-AssadPediatric Endocrine Institute, Ha'Emek Medical Center, Afula, Israel.
Shira LondonPediatric Endocrine Institute, Ha'Emek Medical Center, Afula, Israel.
Marie Noufi-BarhoumPediatric Endocrine Institute, Ha'Emek Medical Center, Afula, Israel.
Hanna LudarPediatric Endocrine Institute, Ha'Emek Medical Center, Afula, Israel.
Tal AlmagorPediatric Endocrine Institute, Ha'Emek Medical Center, Afula, Israel.
Yoav ZehaviPediatric Department, B, Ha'Emek Medical Center, Afula, Israel.
Charles SultanPediatric Endocrinology and Gynecology Unit, CHU de Montpellier, Hôpital Arnaud de Villeneuve et Université Montpellier, Montpellier, France.
Rita BertalanInstitute Pasteur, Rue Dr Roux, Paris, France.
Anu BashambooInstitute Pasteur, Rue Dr Roux, Paris, France.
Kenneth McElreaveyInstitute Pasteur, Rue Dr Roux, Paris, France.
Emek Medical Center · ILInstitut Pasteur · FRHôpital Arnaud de Villeneuve · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveDisorders of sex development (DSD) are defined as congenital conditions in which the development of chromosomal, gonadal and anatomical sex is atypical. Despite wide laboratory and imaging investigations, the etiology of DSD is unknown in over 50% of patients.

methodsWe evaluated the etiology of DSD by whole-exome sequencing (WES) at a mean age of 10 years in nine patients for whom extensive evaluation, including hormonal, imaging and candidate gene approaches, had not identified an etiology.

resultsThe eight 46,XY patients presented with micropenis, cryptorchidism and hypospadias at birth and the 46,XX patient presented with labia majora fusion. In seven patients (78%), pathogenic variants were identified for RXFP2, HSD17B3, WT1, BMP4, POR, CHD7 and SIN3A. In two atients, no causative variants were found. Mutations in three genes were reported previously with different phenotypes: an 11-year-old boy with a novel de novo variant in BMP4; such variants are mainly associated with microphthalmia and in few cases with external genitalia anomalies in males, supporting the role of BMP4 in the development of male external genitalia; a 12-year-old boy with a known pathogenic variant in RXFP2, encoding insulin-like 3 hormone receptor, and previously reported in adult men with cryptorchidism; an 8-year-old boy with syndromic DSD had a de novo deletion in SIN3A.

conclusionsOur findings of molecular etiologies for DSD in 78% of our patients indicate a major role for WES in early DSD diagnosis and management - and highlights the importance of rapid molecular diagnosis in early infancy for sex of rearing decisions.

Indexed as

bone morphogenetic protein 4disorders of sex developmentinsulin-like 3 hormone receptorwhole-exome sequencing

Identifiers

PMID34009138
PMCPMC8240709
OpenAlexW3161082753

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.